Some pathological and clinical factors are important to describe association between Ki67 expression and recurrences in breast cancer patients receiving neoadjuvant chemotherapy—reply

[...]we have interests in examining the biology of residual disease in the primary tumor. [...]we feel that the quality of our data is adequate for analysis because our subjects included many patients with estrogen receptor-negative tumors, who generally develop metastasis 2 to 3 years after surgery...

Full description

Saved in:
Bibliographic Details
Published in:Human pathology 2017-10, Vol.68, p.205-205
Main Author: Horimoto, Yoshiya, MD, PhD
Format: Article
Language:English
Subjects:
Biopsy
Breast cancer
Cancer therapies
Chemotherapy
Clinical trials
Metastasis
Pathology
Patients
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]we have interests in examining the biology of residual disease in the primary tumor. [...]we feel that the quality of our data is adequate for analysis because our subjects included many patients with estrogen receptor-negative tumors, who generally develop metastasis 2 to 3 years after surgery.
ISSN:0046-8177
1532-8392
DOI:10.1016/j.humpath.2017.04.030